Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 48, Issue 4 (Apr 2010)

Issues

Performance evaluation of the Abbott RealTime HCV Genotype II for hepatitis C virus genotyping

Yong-Hak Sohn / Sun-Young Ko
  • Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Myeong Hee Kim
  • Department of Laboratory Medicine, East-West Neo-Medical Center, Kyunghee University, College of Medicine, Seoul, South Korea
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Heung-Bum Oh
  • Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, South Korea
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2010-02-04 | DOI: https://doi.org/10.1515/CCLM.2010.093

Abstract

Background: The Abbott RealTime hepatitis C virus (HCV) Genotype II (Abbott Molecular Inc.) for HCV genotyping, which uses real-time PCR technology, has recently been developed.

Methods: Accuracy and sensitivity of detection were assessed using the HCV RNA PHW202 performance panel (SeraCare Life Sciences). Consistency with restriction fragment mass polymorphism (RFMP) data, cross-reactivity with other viruses, and the ability to detect minor strains in mixtures of genotypes 1 and 2 were evaluated using clinical samples.

Results: All performance panel viruses were correctly genotyped at levels of >500 IU/mL. Results were 100% concordant with RFMP genotypic data (66/66). However, 5% (3/66) of the samples examined displayed probable genotypic cross reactivity. No cross reactivity with other viruses was evident. Minor strains in the mixtures were not effectively distinguished, even at quantities higher than the detection limit.

Conclusions: The Abbott RealTime HCV Genotype II assay was very accurate and yielded results consistent with RFMP data. Although the assay has the advantages of automation and short turnaround time, we suggest that further improvements are necessary before it is used routinely in clinical practice. Efforts are needed to decrease cross reactivity among genotypes and to improve the ability to detect minor genotypes in mixed infections.

Clin Chem Lab Med 2010;48:469–74.

Keywords: genotype; genotyping; HCV; method evaluation; real-time PCR

About the article

Corresponding author: Heung-Bum Oh, MD, Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, 388-1 Pungnap2-dong, Songpa-gu, Seoul 138-736, Korea Phone: +82-2-3010-4505, Fax: +82-2-478-0884,


Received: 2009-10-06

Accepted: 2009-11-24

Published Online: 2010-02-04

Published in Print: 2010-04-01


Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2010.093.

Export Citation

©2010 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Mi-Soon Han, Yongjung Park, and Hyon-Suk Kim
Clinical Chemistry and Laboratory Medicine (CCLM), 2017, Volume 55, Number 8
[2]
Su Rin Shin, Young Seok Kim, Young-Seok Lim, June Sung Lee, Jin Woo Lee, Sun Myung Kim, Sook-Hyang Jeong, Joo Hyun Sohn, Myung Seok Lee, and Sang Hoon Park
Gut and Liver, 2017, Volume 11, Number 2, Page 270
[3]
Melanie A. Mallory, Danijela Lucic, Mark T.W. Ebbert, Gavin A. Cloherty, Dan Toolsie, and David R. Hillyard
Journal of Clinical Virology, 2017, Volume 90, Page 26
[4]
Marlin Benedet, Dena Adachi, Anita Wong, Sallene Wong, Kanti Pabbaraju, Raymond Tellier, and Julian W. Tang
Journal of Clinical Virology, 2014, Volume 60, Number 3, Page 301
[5]
Melanie A. Mallory, Danijela X. Lucic, Mitchell T. Sears, Gavin A. Cloherty, and David R. Hillyard
Journal of Clinical Virology, 2014, Volume 60, Number 1, Page 22
[6]
Paulina Jackowiak, Karolina Kuls, Lucyna Budzko, Anna Mania, Magdalena Figlerowicz, and Marek Figlerowicz
Infection, Genetics and Evolution, 2014, Volume 21, Page 67
[7]
Victoria González, Meissiner Gomes-Fernandes, Elisabet Bascuñana, Sònia Casanovas, Verónica Saludes, Elena Jordana-Lluch, Lurdes Matas, Vicenç Ausina, and Elisa Martró
Journal of Clinical Virology, 2013, Volume 58, Number 3, Page 593
[8]
Victoria González, Meissiner Gomes-Fernandes, Elisabet Bascuñana, Sònia Casanovas, Verónica Saludes, Elena Jordana-Lluch, Lurdes Matas, Vicenç Ausina, and Elisa Martró
Journal of Clinical Virology, 2013, Volume 58, Number 1, Page 249

Comments (0)

Please log in or register to comment.
Log in